Andriushchenko O M, Olesin A I
Ter Arkh. 1996;68(5):57-60.
Antiarrhythmic treatment (AAT) adjusted to the variety of arrhythmia and risk to develop complications was given to 336 patients with ischemic heart disease associated with paroxysms of supraventricular tachycardia (SVT), atrial fibrillation or atrial flutter. In the presence of risk to develop AAT complications, the method of choice for SVT patients is transesophageal pacing and impulse therapy. In the presence of arrhythmic collapse, cardiac asthma and pulmonary edema it is preferable to correct arrhythmia by electric impulse therapy.
对336例患有与阵发性室上性心动过速（SVT）、心房颤动或心房扑动相关的缺血性心脏病患者，给予了根据心律失常类型和发生并发症风险调整的抗心律失常治疗（AAT）。对于存在发生AAT并发症风险的患者，SVT患者的首选方法是经食管起搏和冲动治疗。在出现心律失常性虚脱、心源性哮喘和肺水肿时，通过电冲动治疗纠正心律失常更为可取。
